Covid News and Updates Breaking-AIIMS in Delhi begins Phase-3 trials of COVAXIN from today by Medically Speaking Team November 26, 2020 written by Medically Speaking Team November 26, 2020 All India Institute of Medical Sciences (AIIMS) Delhi has started clinical trials of Bharat BioTech’s indigenous Covid-19 vaccine COVAXIN on humans from today. 0 comment 0 FacebookTwitterPinterestEmail Medically Speaking Team previous post AstraZeneca to run global trials on Covid-19 vaccine Says Pascal Soriot next post Top UK Scientific Adviser says AstraZeneca vaccine works against COVID-19 You may also like The impact of the Covid-19 on lung cancer... May 10, 2023 India reports 7,171 fresh cases of Covid-19 in... April 29, 2023 India reports 7,533 fresh Covid-19 cases in last... April 28, 2023 Post-COVID-19 conditions change a person’s immunological response: Study April 27, 2023 China detects 275 new Covid-19 subvariants in a... April 26, 2023 India reports over 10,000 COVID cases for fifth... April 23, 2023 India reports 11,692 fresh COVID-19 cases in last... April 21, 2023 India reports 12,591 fresh COVID-19 cases in last... April 20, 2023 India reports 10,753 fresh COVID-19 cases in last... April 15, 2023 COVID-19 virus may have originated from humans, claims... April 10, 2023